Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Recombinant Human Interleukin-13 Variant (rHuIL-13 variant)

The human IL-13 cDNA encodes a 132 amino acid protein containing a proposed 20 amino acid signal peptide. Human IL-13 shares approximately 30% amino acid sequence homology to human IL-4 and the two cytokines exhibit overlapping biological activities. Human IL-13 is produced by activated Th0, Th1-like Th2-like and CD8 T cells. Similarly to IL-4, IL-13 has multiple effects on the differentiation and functions of monocytes/macrophages. IL-13 can suppress the cytotoxic functions of monocytes/macrophages. It can also suppress the production of proinflammatory cytokines and upregulate the production of IL-1ra by monocytes/macrophages.

Product Specifications

Source

Escherichia coli.

Field of Research

Immunology & Inflammation

Endotoxin

Less than 1EU/g of rHuIL-13 variant as determined by LAL method.

Purity

>95% by SDS-PAGE and HPLC analyses.

Bioactivity

Fully biologically active when compared to standard. The ED50 as determined by the dose-dependent proliferation of TF-1 cells was 1x106 units/mg. This analog has also been shown to exhibit increased in vivo activity compared to wild type IL-13.

Form

Lyophilized from a 0.2m filtered concentrated solution in PBS, pH 7.2, containing 5% trehalose.

Molecular Weight

Approximately 12.5 kDa, a single non-glycosylated polypeptide chain containing 114 amino acids, with a substitution of Q for R at position 112 compared with the wild type IL-13.

Storage Conditions

This lyophilized preparation is stable for several weeks at 2-8°C, but should be kept at -20°C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8°C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20°C to -70°C. Avoid repeated freeze/thaw cycles.

Notes

For research use only.

Applications Notes

We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/ml. Stock solutions should be apportioned into working aliquots and stored at < -20°C. Further dilutions should be made in appropriate buffered solutions.

Preservative

Lyophilized from a 0.2m filtered concentrated solution in PBS, pH 7.2, containing 5% trehalose.

AA Sequence

SPGPVPPSTA LRELIEELVN ITQNQKAPLC NGSMVWSINL TAGMYCAALE SLINVSGCSA IEKTQRMLSG FCPHKVSAGQ FSSLHVRDTK IEVAQFVKDL LLHLKKLFRE GQFN

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

MYOT Polyclonal Antibody
E-AB-52979-01 20 µL

MYOT Polyclonal Antibody

Sign In for Pricing
View Details
MYOT Polyclonal Antibody
E-AB-52979-02 60 µL

MYOT Polyclonal Antibody

Sign In for Pricing
View Details
MYOT Polyclonal Antibody
E-AB-52979-03 120 µL

MYOT Polyclonal Antibody

Sign In for Pricing
View Details
MYOT Polyclonal Antibody
E-AB-52979-04 200 µL

MYOT Polyclonal Antibody

Sign In for Pricing
View Details
NFKBID (N-term) Rabbit Polyclonal Antibody
AP52864PU-N 400 µL

NFKBID (N-term) Rabbit Polyclonal Antibody

Sign In for Pricing
View Details
IL10 Antibody
KC-532-01 50 μL

IL10 Antibody

Sign In for Pricing
View Details